Literature DB >> 34629705

Current Approach to Planning Angiography and MAA Administration.

Clayton W Commander1, David M Mauro1.   

Abstract

Transarterial radioembolization of primary and secondary hepatic malignancies utilizing yttrium-90 microspheres is a commonly performed treatment by interventional radiologists. Traditionally performed as a two-part procedure, a diagnostic angiography is performed 1 to 3 weeks prior to treatment with the injection of technetium-99m-macroaggregated albumin followed by planar scintigraphy in the nuclear medicine department. Careful attention must be paid to the details during the diagnostic angiography to ensure the delivery of a safe and optimal dose to the diseased liver and to minimize radiation-induced damage to both unaffected liver and adjacent structures. In this article, we will review the steps and considerations that must be made during the angiography planning and discuss current and future areas of research. Thieme. All rights reserved.

Entities:  

Keywords:  diagnostic angiography; interventional radiology; liver cancer; radioembolization; yttrium-90

Year:  2021        PMID: 34629705      PMCID: PMC8497078          DOI: 10.1055/s-0041-1735616

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.780


  27 in total

1.  Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients.

Authors:  Anne M Covey; Lynn A Brody; Mary A Maluccio; George I Getrajdman; Karen T Brown
Journal:  Radiology       Date:  2002-08       Impact factor: 11.105

2.  Prophylactic embolization of the gastroduodenal and right gastric arteries is not routinely necessary before radioembolization with glass microspheres.

Authors:  Nabeel Hamoui; Jeet Minocha; Khairuddin Memon; Kent Sato; Robert Ryu; Riad Salem; Robert J Lewandowski
Journal:  J Vasc Interv Radiol       Date:  2013-11       Impact factor: 3.464

3.  Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies.

Authors:  William A Dezarn; Jeffery T Cessna; Larry A DeWerd; Wenzheng Feng; Vanessa L Gates; James Halama; Andrew S Kennedy; Subir Nag; Mehrdad Sarfaraz; Varun Sehgal; Reed Selwyn; Michael G Stabin; Bruce R Thomadsen; Lawrence E Williams; Riad Salem
Journal:  Med Phys       Date:  2011-08       Impact factor: 4.071

Review 4.  Radioembolization of Hepatic Malignancies: Background, Quality Improvement Guidelines, and Future Directions.

Authors:  Siddharth A Padia; Robert J Lewandowski; Guy E Johnson; Daniel Y Sze; Thomas J Ward; Ron C Gaba; Mark O Baerlocher; Vanessa L Gates; Ahsun Riaz; Daniel B Brown; Nasir H Siddiqi; T Gregory Walker; James E Silberzweig; Jason W Mitchell; Boris Nikolic; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2016-11-09       Impact factor: 3.464

5.  Outpatient single-session yttrium-90 glass microsphere radioembolization.

Authors:  Vanessa L Gates; Karen G Marshall; Krystina Salzig; Melissa Williams; Robert J Lewandowski; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2013-12-12       Impact factor: 3.464

6.  Biliary sequelae following radioembolization with Yttrium-90 microspheres.

Authors:  Bassel Atassi; Affaan K Bangash; Robert J Lewandowski; Saad Ibrahim; Laura Kulik; Mary F Mulcahy; Ravi Murthy; Robert K Ryu; Kent T Sato; Frank H Miller; Reed A Omary; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2008-03-17       Impact factor: 3.464

7.  Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.

Authors:  Andrew Kennedy; Subir Nag; Riad Salem; Ravi Murthy; Alexander J McEwan; Charles Nutting; Al Benson; Joseph Espat; Jose Ignacio Bilbao; Ricky A Sharma; James P Thomas; Douglas Coldwell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-01       Impact factor: 7.038

8.  Same-day 90Y radioembolization: implementing a new treatment paradigm.

Authors:  Ahmed Gabr; Joseph Ralph Kallini; Vanessa L Gates; Ryan Hickey; Laura Kulik; Kush Desai; Bartley Thornburg; Karen Marshall; Krystina Salzig; Melissa Williams; Carlene Del Castillo; Daniel Ganger; Elias Hohlastos; Talia Baker; Robert J Lewandowski; Riad Salem
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-17       Impact factor: 9.236

9.  Early arterial stasis during resin-based yttrium-90 radioembolization: incidence and preliminary outcomes.

Authors:  Peachy Mae Piana; Voichita Bar; Laura Doyle; Rani Anne; Takami Sato; David J Eschelman; Jeffrey W McCann; Carin F Gonsalves; Daniel B Brown
Journal:  HPB (Oxford)       Date:  2013-06-19       Impact factor: 3.647

Review 10.  Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.

Authors:  Etienne Garin; Yan Rolland; Sophie Laffont; Julien Edeline
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-04       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.